Clinical Trials Browser

Phase 3 × Rectal Neoplasms × Adjuvants, Pharmaceutic × Clear all

NCT04495088 2026-02-02

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

Phase 3 Recruiting

Gastrointestinal

Rectal Neoplasms